Glutamatergic Mechanisms: Aim2
Clinical trial NCT05401227 · RECRUITING
Trial details
- NCT number
- NCT05401227
- Sponsor
- New York State Psychiatric Institute
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-15
- Primary completion
- 2028-08-01
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.